Published by Bupa's Health Information Team, December 2010.
This factsheet is for people who have chronic myeloid leukaemia, or who would like information about it.
Chronic leukaemia is a cancer of the blood that develops slowly. Chronic myeloid leukaemia (CML) affects a type of blood cell called myeloid cells and is most common in people aged between 40 and 60.
The term leukaemia refers to a group of cancers of the blood cells and bone marrow. If you have leukaemia, your white blood cells become abnormal and divide and grow in an uncontrolled way.
Leukaemia is described as acute (growing rapidly) or chronic (growing slowly). Chronic leukaemia is divided into two main types – CML and chronic lymphocytic leukaemia (CLL). This factsheet focuses on CML.
In CML, cells in your blood known as myeloid cells become cancerous. Myeloid cells are responsible for producing many of the other types of cell in your blood – including red cells, platelets and a type of white blood cell known as granulocytes. In CML, your blood cells, particularly the granulocytes, become abnormal and grow out of control. Because it affects the granulocytes, this condition is also sometimes called chronic granulocytic leukaemia.
In the early stages of the disease, your blood cells may still function reasonably normally. However, if you don’t get effective treatment, the disease can transform into a more malignant condition with more severe symptoms.
About 700 people in the UK are diagnosed with CML each year. It's most common in people aged between 40 and 60 but it can occur at any age. It's very rare in children.
Symptoms of CML in the early stages of the disease can include:
You may not have any symptoms at first and many of the symptoms are vague and can be confused with common illnesses like flu. In fact, around one in four people with CML don’t have any symptoms at all but their CML is picked up during a routine blood test.
If you have a more advanced form of CML, you may also notice further symptoms such as:
These symptoms aren't always due to CML, but if you have them, see your GP.
Most people develop CML because an abnormality develops in a chromosome in their myeloid cells. This is called the Philadelphia chromosome. Chromosomes are structures that contain genes – these contain the instructions for life and are inherited from your parents. The Philadelphia chromosome carries an abnormal gene called BCR-ABL. You’re not born with the Philadelphia chromosome but develop it by chance at some point during your life. The reasons why you may develop it are not fully understood, but there seem to be several risk factors. These include:
Your GP will ask about your symptoms and examine you. He or she may ask you to have a blood test to check the levels of different cells in your blood. If your GP thinks that you may have CML, he or she will refer you to a specialist called a haematologist (a doctor who specialises in conditions of the blood).
The haematologist will carry out some further investigations to confirm whether you are suffering from leukaemia and if so, whether it is CML. These tests may include:
These tests are important because they help determine which treatment is best for you.
You may hear your doctors referring to stages of cancer. These stages measure how far your leukaemia has progressed so that you’re provided with the most appropriate treatment.
There are three stages of CML.
Your treatment will depend on the stage of CML and on your general health. It may include a combination of different therapies. If your disease is in the chronic phase, your treatment will be aimed at controlling your symptoms for as long as possible. If you have accelerated or blast phase CML, your treatment will be aimed at reducing your symptoms and putting your leukaemia back into a chronic phase.
Your doctor will usually prescribe you a medicine called imatinib to take. Imatinib is a type of medicine called a tyrosine kinase inhibitor. It’s taken by mouth and has few side-effects in most people. Imatinib works by blocking the signals that make the cancer cells grow and multiply, and can get rid of the Philadelphia chromosome from your blood and bone marrow. In many people with CML, it keeps the disease under control for many years.
Imatinib can be used to control your symptoms if you have chronic phase CML. You can also take it if you have accelerated or blast stage CML, as long as you haven’t taken it before. You can continue taking imatinib for as long as it’s controlling your symptoms. Your doctor will monitor you carefully, taking blood tests to check you are still in remission.
If imatinib isn’t working for you or if you’re having severe side-effects, your doctor may suggest taking a newer alternative tyrosine kinase inhibitor, such as dasatinib or nilotinib; however these may not be widely available.
Interferon alpha is another medicine that is used occasionally to treat CML. It can be combined with chemotherapy. Side-effects include headache, fever and depression.
You may need to have chemotherapy if you haven’t responded to other treatment. Chemotherapy uses medicines to destroy leukaemic cells in your bone marrow. Chemotherapy for CML is usually with tablets of a medicine called hydroxycarbamide. Hydroxycarbamide is able to fully control chronic phase CML and most people have very few side-effects. However, the drug cannot destroy the Philadelphia chromosome and so the disease can still progress to the accelerated or blast phases.
If you have accelerated or blastic phase CML, you may need to have high-dose chemotherapy. This may involve a combination of drugs, given into your vein.
If you haven’t responded well to other treatments, your doctor may suggest that you have a bone marrow (stem cell) transplant (preferably from a brother or sister) into your body. It can effectively cure CML.
You need to be in general good health to have this treatment.
New potential treatments that are being investigated for CML include a chemotherapy medicine called omacetaxine and mini-stem cell transplants. Research is also being carried out on vaccines for CML. Many people with leukaemia take part in clinical trials as treatments are constantly changing. Your doctor can give you more information about clinical trials.
For answers to frequently asked questions on this topic, see Common questions.
For sources and links to further information, see Resources.
Bupa can offer NHS and private patients professional cancer care and support at home including IV and oral chemotherapy via our Chemotherapy at Home Service.
Already a member? Find a Bupa approved cancer unit near you including breast, bowel and gynaecological specialist units.
This information was published by Bupa's Health Information Team and is based on reputable sources of medical evidence. It has been reviewed by appropriate medical or clinical professionals. Photos are only for illustrative purposes and do not reflect every presentation of a condition. The content is intended only for general information and does not replace the need for personal advice from a qualified health professional. For more details on how we produce our content and its sources, visit the About our Health Information page.
Publication date: December 2010
1 in 3 people will get cancer in their lifetime